Case Studies

Digistain® works biologically downstream using a proprietary method to measure markers at the protein level to deliver a robust and personalised risk score for cancer therapy guidance

Case Studies

Clinical Case Study - Identification of High Risk Patient
hr
Clinical Case Study - Identification Low Risk Patient
lr

Subscribe to leading news and insights

To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.